RAFFA WEALTH MANAGEMENT, LLC’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $85 | Hold |
9
| – | – | ﹤0.01% | 1422 |
|
|
2026
Q1 | $73 | Hold |
9
| – | – | ﹤0.01% | 1342 |
|
|
2025
Q4 | $60 | Hold |
9
| – | – | ﹤0.01% | 1155 |
|
|
2025
Q3 | $78 | Hold |
9
| – | – | ﹤0.01% | 1162 |
|
|
2025
Q2 | $57 | Hold |
9
| – | – | ﹤0.01% | 1095 |
|
|
2025
Q1 | $58 | Hold |
9
| – | – | ﹤0.01% | 1070 |
|
|
2024
Q4 | $72 | Hold |
9
| – | – | ﹤0.01% | 1102 |
|
|
2024
Q3 | $114 | Hold |
9
| – | – | ﹤0.01% | 1068 |
|
|
2024
Q2 | $114 | Hold |
9
| – | – | ﹤0.01% | 1134 |
|
|
2024
Q1 | $43 | Hold |
9
| – | – | ﹤0.01% | 1125 |
|
|
2023
Q4 | $43 | Hold |
9
| – | – | ﹤0.01% | 1057 |
|
|
2023
Q3 | $65 | Hold |
9
| – | – | ﹤0.01% | 1053 |
|
|
2023
Q2 | $67 | Hold |
9
| – | – | ﹤0.01% | 1061 |
|
|
2023
Q1 | $62 | Hold |
9
| – | – | ﹤0.01% | 1065 |
|
|
2022
Q4 | $93 | Hold |
9
| – | – | ﹤0.01% | 1054 |
|
|
2022
Q3 | $164 | Hold |
9
| – | – | ﹤0.01% | 1141 |
|
|
2022
Q2 | $463 | Hold |
9
| – | – | ﹤0.01% | 1034 |
|
|
2022
Q1 | $663 | Hold |
9
| – | – | ﹤0.01% | 991 |
|
|
2021
Q4 | $1.29K | Hold |
9
| – | – | ﹤0.01% | 791 |
|
|
2021
Q3 | $1.87K | Buy |
9
+7
| +350% | +$1.54K | ﹤0.01% | 634 |
|
|
2021
Q2 | $425 | Hold |
2
| – | – | ﹤0.01% | 1065 |
|
|
2021
Q1 | $363 | Buy |
+2
| New | +$399 | ﹤0.01% | 1075 |
|
|
2019
Q4 | – | Sell |
-350
| Closed | -$1.76K | – | 744 |
|
|
2019
Q3 | $1.76K | Buy |
+350
| New | +$1.92K | ﹤0.01% | 423 |
|
|
2019
Q2 | – | Sell |
-350
| Closed | -$3.86K | – | 1178 |
|
|
2019
Q1 | $3.86K | Hold |
350
| – | – | ﹤0.01% | 264 |
|
|
2018
Q4 | $12.9K | Hold |
350
| – | – | ﹤0.01% | 195 |
|
|
2018
Q3 | $13.2K | Hold |
350
| – | – | ﹤0.01% | 200 |
|
|
2018
Q2 | $9.38K | Hold |
350
| – | – | ﹤0.01% | 210 |
|
|
2018
Q1 | $14.7K | Hold |
350
| – | – | 0.01% | 186 |
|
|
2017
Q4 | $8.68K | Hold |
350
| – | – | ﹤0.01% | 199 |
|
|
2017
Q3 | $7.98K | Hold |
350
| – | – | ﹤0.01% | 214 |
|
|
2017
Q2 | $8.05K | Hold |
350
| – | – | ﹤0.01% | 209 |
|
|
2017
Q1 | $8.96K | Buy |
350
+175
| +100% | +$4.81K | ﹤0.01% | 178 |
|
|
2016
Q4 | $4.41K | Hold |
175
| – | – | ﹤0.01% | 228 |
|
|
2016
Q3 | $7.28K | Buy |
175
+169
| +2,817% | +$21.8K | ﹤0.01% | 198 |
|
|
2016
Q2 | $872 | Hold |
6
| – | – | ﹤0.01% | 438 |
|
|
2016
Q1 | $619 | Buy |
+6
| New | +$644 | ﹤0.01% | 600 |
|
Other funds holding NVAX
S
OAM
PAG
PFSRSONJ
YIH
SS
KAS
IFG
CUAMC
RAFFA WEALTH MANAGEMENT, LLC's NVAX Position: Q2 2026 in Review
RAFFA WEALTH MANAGEMENT, LLC held its Novavax (NVAX) position steady in Q2 2026 at 9 shares worth $85. The position accounts for ﹤0.01% of the portfolio, ranked #1422.
RAFFA WEALTH MANAGEMENT, LLC first reported a position in NVAX in Q1 2016 and has held it in 36 quarters since. The position peaked at $14.7K in Q1 2018. 51 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- RAFFA WEALTH MANAGEMENT, LLC held 9 shares of Novavax worth $85 as of Q2 2026.
- RAFFA WEALTH MANAGEMENT, LLC left its Novavax share count unchanged in Q2 2026.
- Novavax made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #1422 holding.
- RAFFA WEALTH MANAGEMENT, LLC first reported a position in Novavax in Q1 2016 and has held it in 36 quarters since.
- RAFFA WEALTH MANAGEMENT, LLC's Novavax position peaked at $14.7K in Q1 2018.
- 51 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.